Documentaries, videos and podcasts
May 5, 2021
, , , , • BASF will invest at Novartis' Kundl/Schaftenau Campus, in Austria , , • Target is to further develop a world-scale production set-up for bacterial enzymes and biotechnology products , , • With this investment, BASF strengthens its position in the enzymes and biotechnology market , , , , , , On April 26, 2021 BASF has agreed with Sandoz GmbH, a subsidiary of Novartis, to invest at the Kundl/Schaftenau Campus in Austria. This agreement enables BASF to further develop its production footprin...
March 11, 2021
BASF has recently signed two distinct partnerships agreements to expand its global leading position in the bio-based surfactants and actives market. The strategic alliance with ACS includes an equity stake and makes BASF the single largest shareholder. It further entails an exclusive technology cooperation, commercial agreement and product development for sophorolipids, one class of glycolipids, to address the ever-increasing needs of consumers for sustainable, natural and bio-degradable i...
January 31, 2020
, , , , • Underlying sales growth was 2.9% with 1.2% volume and 1.6% price, , • Underlying operating margin increased 50bps, , • Turnover increased 2.0%, , • Free cash flow increased €0.7 billion to €6.1 billion, , • Underlying earnings per share increased 8.1%, , , , , , Comment from CEO Alan Jope "In 2019 we delivered underlying sales growth of 2.9%, balanced between price and volume, a further year of good margin and earnings progression, and strong free cash flow. We saw strong growth from emerging m...
Be the first contributor by making edits